[1]
“High rate prevalence of asymptomatic SARS-CoV-2 infection: Comparative epidemiology with other pandemic flu and impact on COVID 19 control measures”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 4, pp. 415–421, Jul. 2020, doi: 10.25004/IJPSDR.2020.120415.